Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 16/01/25 3:58pm ...

Canaccord said Science Group has an impressive and consistent track record of delivering a combination of organic and disciplined inorganic growth with minimal shareholder dilution. "This track ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per ...

In addition to a Reuters report stating the EV specialist was seeing seeing strong sales in China, the company's stock is also getting a boost from a price target increase from Canaccord.

Canaccord weighed in on Tesla in new coverage, issuing a buy rating on the stock and raising its one-year price target from $298 per share to $404 per share. In addition to bullish momentum for ...

Dr. Zachary Levi accused UnitedHealthcare of denying the claims of one of his patients in a coma in a now-deleted post on X. Screenshots of the same have since been going viral as Levy took down the ...

DALLAS — Dallas Fire-Rescue said it is investigating the cause of a house fire that resulted in a man's death Friday afternoon. According to DFR, units were assigned to the house fire in the ...

"Shazam!" star Zachary Levi feels a biblical disaster looming, thanks to artificial intelligence. On the "The George Janko Show" podcast, Levi compared AI to the great flood from the book of ...

Canaccord analyst George Gianarikas raised the firm’s price target on Tesla (TSLA) to $404 from $298 and keeps a Buy rating on the shares. The firm says that despite Tesla’s weaker than ...